发明名称 Pharmaceutical Formulation Containing Gelling Agent
摘要 Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
申请公布号 US2017020863(A1) 申请公布日期 2017.01.26
申请号 US201615284706 申请日期 2016.10.04
申请人 Purdue Pharma L.P. 发明人 Wright Curtis;Oshlack Benjamin;Breder Christopher
分类号 A61K31/485;A61K9/48;A61K47/38;A61K47/02;A61K9/00;A61K47/14 主分类号 A61K31/485
代理机构 代理人
主权项
地址 Stamford CT US